Bone Morphogenetic Proteins Market, Global Outlook and Forecast 2023-2029

Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens.Originally discovered by their ability to induce the formation of bone and cartilage, BMPs are now considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body.
This report aims to provide a comprehensive presentation of the global market for Bone Morphogenetic Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Morphogenetic Proteins. This report contains market size and forecasts of Bone Morphogenetic Proteins in global, including the following market information:
Global Bone Morphogenetic Proteins Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bone Morphogenetic Proteins Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Bone Morphogenetic Proteins companies in 2022 (%)
The global Bone Morphogenetic Proteins market was valued at US$ 443.5 million in 2022 and is projected to reach US$ 523.4 million by 2029, at a CAGR of 2.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
rhBMP-2 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bone Morphogenetic Proteins include Medtronic, Cellumed, Stryker, Sigma Aldrich, ProSpec, Ember therapeutics, R&D Systems and Thermo Fischer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bone Morphogenetic Proteins manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bone Morphogenetic Proteins Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Bone Morphogenetic Proteins Market Segment Percentages, by Type, 2022 (%)
    rhBMP-2
    rhBMP-7
Global Bone Morphogenetic Proteins Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Bone Morphogenetic Proteins Market Segment Percentages, by Application, 2022 (%)
    Spinal Fusion
    Trauma
    Reconstructive Surgery
    Oral-Maxillofacial
    Others
Global Bone Morphogenetic Proteins Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Bone Morphogenetic Proteins Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bone Morphogenetic Proteins revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bone Morphogenetic Proteins revenues share in global market, 2022 (%)
Key companies Bone Morphogenetic Proteins sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Bone Morphogenetic Proteins sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Medtronic
    Cellumed
    Stryker
    Sigma Aldrich
    ProSpec
    Ember therapeutics
    R&D Systems
    Thermo Fischer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bone Morphogenetic Proteins, market overview.
Chapter 2: Global Bone Morphogenetic Proteins market size in revenue and volume.
Chapter 3: Detailed analysis of Bone Morphogenetic Proteins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bone Morphogenetic Proteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bone Morphogenetic Proteins capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.